In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Stryker trades slightly above fair value (-1.8% downside), supported by high-confidence DCF and analyst targets indicating mixed valuation signals. Financial health is good, with strong liquidity and profitability but moderate leverage and growth scores. Monte Carlo shows high volatility and significant downside risk (58.3%), implying elevated investment uncertainty despite potential upside.